SCHEMBL1032832

SCHEMBL1032832

N#Cc1cccc(-c2ccnc(NC3CCCCC3)n2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.57
ROCK2 O75116 1/20 0.52
CCNA2 P20248 2/20 0.51
CDK2 P24941 2/20 0.51
MAPK3 P27361 1/20 0.51
MAPK1 P28482 1/20 0.51
CDK1 P06493 3/20 0.50
CCNB1 P14635 3/20 0.50
MAPK14 Q16539 2/20 0.50
CCNB2 O95067 2/20 0.50
GSK3B P49841 2/20 0.50
CCNB3 Q8WWL7 2/20 0.50
CDC7 O00311 1/20 0.50
PLK4 O00444 1/20 0.50
JAK2 O60674 1/20 0.50
MAP4K4 O95819 1/20 0.50
INSR P06213 1/20 0.50
CSF1R P07333 1/20 0.50
PIM1 P11309 1/20 0.50
PRKACA P17612 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1033626 0.81 CDK1 (0.53) CTSKCCNA2CDK2MAPK1CDK1
SCHEMBL1028968 0.81 MAP4K4 (0.55) CTSKROCK2CCNA2CDK2MAPK3
SCHEMBL3619159 0.81 ADORA1 (0.59) CCNA2CDK2MAPK3MAPK1CDK1
SCHEMBL1030530 0.81 ADORA1 (0.59) CCNA2CDK2MAPK3MAPK1CDK1
SCHEMBL6104690 0.80 MAPK14 (0.45) CTSKROCK2CCNA2CDK2MAPK3
SCHEMBL5421285 0.80 MAPK14 (0.48) CTSKROCK2CCNA2CDK2MAPK3
SCHEMBL1033097 0.79 MKNK1 (0.57) CCNA2CDK2MAPK3MAPK1CDK1
SCHEMBL5427924 0.78 MAPK14 (0.47) CTSKROCK2CCNA2CDK2MAPK3
SCHEMBL1032945 0.78 CDK1 (0.49) CTSKCCNA2CDK2MAPK1CDK1
SCHEMBL1030447 0.78 MAPK14 (0.52) ROCK2CDK1CCNB1MAPK14CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed